Evidence map›Paper›PMID 31818402›Full record

ArticleLancet (London, England)2019

Ivermectin for the control of scabies outbreaks in the UK.

Jo Middleton, Stephen L Walker, Thomas House, Michael G Head, Jackie A Cassel

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. [Scabies-Renaissance of an ectoparasite infection : Diagnosis and therapy-How to proceed in practice].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021
    Review
  4. Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic.Journal of the European Academy of Dermatology and Venereology : JEADV · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Jo MiddletonDepartment of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer BN1 9PH, UK; Evolution, Behaviour and Environment, School of Life Sciences, University of Sussex, Falmer, UK. Electronic address: j.middleton@bsms.ac.uk.
Stephen L WalkerFaculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; Hospital for Tropical Diseases and Department of Dermatology, University College London Hospitals NHS Foundation Trust, London, UK.
Thomas HouseSchool of Mathematics, University of Manchester, Manchester, UK.
Michael G HeadFaculty of Medicine and Global Health Research Institute, University of Southampton, Southampton, UK.
Jackie A CasselDepartment of Primary Care and Public Health, Brighton and Sussex Medical School, Falmer BN1 9PH, UK; Surrey and Sussex Health Protection Team, Public Health England, Horsham, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

InsecticidesScabiesAntiparasitic AgentsDisease OutbreaksHumansIvermectinUnited KingdomAntiparasitic AgentsInsecticidesIvermectin

Identifiers

PMID31818402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.